Latest From Biotech Now

Future Requires Both Innovation and Collaboration

Paul Schickler DuPont

The Wilmington News Journal’s recent article, “GMOs: 10 Simple Questions (and Some Surprising Answers)” garnered a lot of attention on both sides of the debate around biotech foods.  Among the responses, a thoughtful piece authored by Pioneer Hi-Bred president Paul Schickler was published in the paper’s Sunday edition: Biotech crops are perhaps the most stringently regulated aspect of agriculture – held to the highest level of analysis and scrutiny. They are regulated by three federal Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Podcast: Ethics of Global Clinical Trials

Dr. Russell Medford

Holland & Knight’s Michael Werner talks to Dr. Russell Medford, President and CEO of Salutria Pharmaceuticals, a privately-held biotech company based in Alpharetta Georgia. Dr. Medford is also co-chair of BIO’s Board Standing Committee on Bioethics. Dr. Medford will be providing testimony on Wednesday November 16 to the Presidential Commission for the Study of Bioethical Issues on Principles Regarding Ethical Performance of International Clinical Trials.

Health  |  Leave a comment  |  Email This Post

The Ethics of Global Clinical Trials

Dr. Russell Medford

By Dr. Russell Medford, Salutria Pharmaceuticals Recent reports have raised concerns about how clinical trials are being performed in other countries, particularly in the developing world. Even prior to these reports, some have asserted that sponsors conduct clinical trials abroad to avoid red tape and avoid overly stringent and time consuming regulatory processes. However, research done by companies with the intent of seeking FDA approval and access to the U.S. market must still meet FDA standards Read More >

Health  |  2 Comments  |  Email This Post
Tags: , , , , , ,

World Pneumonia Day: November 12

Pneumonia-Vax-thumb

November 12 marks World Pneumonia Day, a campaign to educate the public about this disease and to advocate for global action to treat and prevent it. Pneumonia is the leading cause of death globally for children under the age of 5, claiming the lives of more than 1.5 million children annually. Pneumonia is also largely a vaccine-preventable disease. Since the introduction of pneumococcal vaccines in the U.S. in 2000, morbidity and mortality from pneumonia have Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Foundation Fighting Blindness Invests in Gene Therapy Research Projects

567497167_0ee54c371c_z

Recently, the Foundation Fighting Blindness announced an $8.25 million investment in six new gene therapy research projects targeted to have treatments ready for clinical trials within three years. The projects include the following: The Institut de la Vision in Paris and the Friedrich Miescher Institute in Basel, Switzerland, are developing a gene therapy that may revive degenerating cones and potentially enable them to regain their ability to respond to light and provide vision. The treatment Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,